MSH2 deficiency abolishes the anticancer and pro-aging activity of short telomeres. (Q53441691)
Jump to navigation
Jump to search
scientific article published in February 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MSH2 deficiency abolishes the anticancer and pro-aging activity of short telomeres. |
scientific article published in February 2009 |
Statements
MSH2 deficiency abolishes the anticancer and pro-aging activity of short telomeres. (English)
1 reference
Paula Martinez
1 reference
Irene Siegl-Cachedenier
1 reference
Juana M Flores
1 reference
1 February 2009
1 reference
1 reference
8
1 reference
1
1 reference
2-17
1 reference
Identifiers
1 reference